Harold Rogers Prescription Drug Monitoring Program


Goals: To enhance the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data through a centralized database administered by an authorized state agency and federally recognized Indian tribal governments. Objectives: Implement and enhance prescription drug monitoring programs. Develop and enhance public safety, behavioral health, and public health information sharing partnerships that leverage key public health and public safety data sets (e.g., identified PDMP data, naloxone administrations, fatal and non-fatal overdose data, drug arrests) and develop interventions based on this information. Performance Measure 1: Percent of grantees with a registered prescriber rate above 65% in their state PDMPs. Performance Measure 2: Did you develop any data-sharing agreements during the reporting period? Performance Measure 3: Did you identify any hotspots as a result of any analyses done during the reporting period?

General information about this opportunity
Last Known Status
Program Number
Federal Agency/Office
Office of Justice Programs, Department of Justice
Type(s) of Assistance Offered
B - Project Grants
Program Accomplishments
Not applicable.
Department of Justice Appropriations Act, 2023, Public Law 117-328, Statute 136,4459, 4537
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
The following entities are eligible to apply: o State governments and U.S. territories that have an enabling statute or regulation (pending or enacted) requiring the submission of controlled substance prescription data to an authorized state agency. o Applicants within a state that does not have such an enabling statute are eligible to apply as a city, county, or region if (a) the city, county, or region has enacted an enabling statute, ordinance, or regulation requiring the submission of controlled substance prescription data to an authorized city, county, or region; (b) the city, county, or region agrees to transfer the PDMP system to an authorized state agency if the state adopts an enabling state statute requiring the submission of controlled substance prescription data to an authorized state agency; and (c) the city, county, or region ensures that all vendor contracts are written to permit the transfer of ownership of the system to the authorized state agency.
Beneficiary Eligibility
Not applicable.
The applicant must submit a completed Application for Federal Assistance (Standard Form 424), including signed assurances that it will comply with statutory and administrative requirements. By certifying on-line, the authorizing signing official is also assuring that all federal certifications and assurances are being met. The certification and assurance forms (Assurances, OJP Form 4000/3 and Certifications Regarding Lobbying; Debarment, Suspension and Other Responsibility Matters; and Drug-Free Workplace Requirements, OJP Form 4061/6) are provided on-line to allow applicants to review and accept them electronically.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is required. No formal pre application coordination is required. While informal pre application coordination is not required, it is encouraged that applicants coordinate with any facilities for which they have responsibility to detain or incarcerate undocumented criminal aliens.
Application Procedure
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applications are submitted to DOJ in a two-step process. Step 1: Applicants will submit an SF-424 and an SF-LLL in Grants.gov at https://www.grants.gov/web/grants/register.html. To register in Grants.gov, applicants will need to obtain a Data Universal Numbering System (DUNS) and System for Award Management (SAM) registration or renewal. Step 2: Applicants will submit the full application, including attachments, in JustGrants at https://justicegrants.usdoj.gov/. To be considered timely, an application must be submitted by the application deadline using Grants.gov, and the applicant must have received a validation message from Grants.gov that indicates successful and timely submission. OJP urges applicants to submit applications at least 72 hours prior to the application due date to allow time for the applicant to receive validation messages or rejection notifications from Grants.gov and to correct in a timely fashion any problems that may have caused a rejection notification.
Award Procedure
Upon approval by the Office of Justice Programs Assistant Attorney General, successful applicants are notified via DOJ's Justice Grants System (JustGrants). The grant award must be accepted electronically by the receiving organizations authorized official in JustGrants.
Contact the headquarters or regional location, as appropriate for application deadlines
Approval/Disapproval Decision Time
Applications will generally be approved or denied within 60 days of receipt of a complete application.
Not applicable.
Not applicable.
How are proposals selected?
For selection criteria and required elements see the current fiscal year's solicitation available at the Office of Justice Programs web site at https://ojp.gov/funding/Explore/CurrentFundingOpportunities.htm.
How may assistance be used?
The Harold Rogers Prescription Drug Monitoring Program (PDMP) allows for states’ discretion as they plan, implement, or enhance a PDMP to accommodate local decision-making based on state laws and preferences, while encouraging the replication of promising practices. The Harold Rogers PDMP strengthens states’ and territories’ ability to plan, implement, or enhance PDMPs by accommodating local decision-making based on state laws and preferences, while encouraging the replication of promising practices. In addition to supporting the implementation and enhancement of PDMPs, the program can support the Administration’s priority of tracking prescribing across providers and states through the integration of PDMPs and Electronic Health Records (EHRs) and Health Information Exchanges (HIEs) which are essential to promoting safe and responsible prescribing, while also assuring appropriate pain care. Grant funds may be used to support a variety of PDMP implementation or enhancement activities that encourage the use of PDMPs to improve clinical decision-making and prevent the abuse and diversion of controlled substances.
What are the requirements after being awarded this opportunity?
Performance Reports: To assist in fulfilling the Departments responsibilities under the Government Performance and Results Act of 1993 (GPRA), Public Law 103-62, and the GPRA Modernization Act of 2010, Public Law 111–352, recipients must provide data that measures the results of their work.
Not applicable.
In accordance with the requirement set forth in 2 CFR 200, Subpart F, grantees must maintain all financial records, supporting documents, statistical records, and all other records pertinent to the award for at least 3 years following the close of the most recent audit.
Other Assistance Considerations
Formula and Matching Requirements
Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing.
Length and Time Phasing of Assistance
The terms for these grant program budget periods are typically 18 months in duration. See the following for information on how assistance is awarded/release: See the Department of Justice Grants Financial Guide section on “Period of Availability of Funds" at https://www.ojp.gov/funding/financialguidedoj/iii-postaward-requirements.
Who do I contact about this opportunity?
Regional or Local Office
None/Not specified.
Headquarters Office
Rebecca Rose
U.S. Department of Justice
Office of Justice Programs
Bureau of Justice Assistance
810 7th Street, NW
Washington, DC 20531 USA
Phone: (202) 598-9314
Website Address
Financial Information
Account Identification
(Project Grants) FY 22$45,509,360.00; FY 23 est $35,000,000.00; FY 24 est $33,000,000.00; FY 21$24,976,549.00; FY 20$28,267,571.00; FY 19$26,904,976.00; FY 18$27,278,008.00; FY 17$12,841,705.00; FY 16$11,162,933.00; -
Range and Average of Financial Assistance
See the current fiscal year's solicitation available at the Office of Justice Programs web site ( https://www.ojp.gov/funding/explore/current-funding-opportunities).
Regulations, Guidelines and Literature
Office of Justice Programs funding opportunities https://www.ojp.gov/funding/explore/current-funding-opportunities Department of Justice Grants Financial Guide (https://www.ojp.gov/funding/financialguidedoj/overview) and Post award Instructions (https://www.ojp.gov/funding/financialguidedoj/iii-postaward-requirements), applicable OMB Circulars and regulations, and Department of Justice regulations applicable to specific types of grantees.
Examples of Funded Projects
Fiscal Year 2018 Funding will be provided to add provider dashboard enhancements to the PDMP that support clinical decision-making. Funding will also develop updated training for prescribers, dispensers, and designees on the provider dashboard enhancements and produce updated training videos.
Fiscal Year 2019 The PDMP will employ an epidemiologist to provide data analysis to inform and guide health care practitioners and policy makers and expanding existing outreach and education. The PDMP will also fund integration of PDMP information into clinical workflow by providing mini-grants to small physician practices and independent pharmacies
Fiscal Year 2020 The PDMP will create a statewide data-sharing infrastructure, with a single data repository/database; an interactive web portal accessible by law enforcement, criminal justice, and healthcare stakeholders; and syndromic drug overdose surveillance via dashboards and heat maps. The objectives of the project are to: promote cross-system planning and coordination of opioid use disorder prevention and treatment interventions through information-sharing partnerships with key stakeholders; increase the timeliness, comprehensiveness and reporting of fatal and nonfatal opioid overdose data; disseminate surveillance findings to key stakeholders and policy makers to inform prevention and response efforts; and monitor use of the data-sharing system and implement ongoing quality controls.
Fiscal Year 2022 • Provide training for system users. • Support collaboration among law enforcement, prosecutors, public health officials, treatment providers, and drug courts. • Facilitate electronic information sharing among states in compliance with the Prescription Monitoring Information Exchange (PMIX) National Architecture. • Develop different methods for collecting information. • Identify differences in the various PDMP procedures, rules, state regulations, capabilities, and polices. • Bring together stakeholders with different perspectives, sets of information, and methodologies to examine the impact of various policies and procedures on patients and the community. • Implement proven practices on a larger scale.


Federal Grants Resources